Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Opioid Receptor Antagonists for Acute Treatment of Paraphilic Arousal States

06.09.2012
The treatment of paraphilias and related disorders has been challenging for patients and clinicians for a long time. The main problems of recent drug therapies are their occurring side effects, mostly the affection not only of the sexual but of the overall behaviour of the patient. Therefore compliance and willingness to use such treatment options is really poor.</p>The present invention provides a method for acute treatment of paraphilic sexual arousal states in patients suffering from paraphilia by administering an opioid receptor antagonist.</p>

<p>In contrast to common therapies the patient is treated with said medicament, only if he is in acute need in order to acutely diminish a paraphilic sexual arousal state.  According to the present invention the opioid receptor antagonist is preferably be administered nasally. Within 5 to 10 minutes after treatment, the patient is able to control his behavior, thus avoiding any actions that may harm the patient or his environment. <br> <br> Because the patient is only exposed to the drug if he is in acute need for it, development of side effects from known therapies is reduced. This leads to an increased compliance and willingness to accept such treatment.</p> <strong>Benefits</strong>

<ul> <li>Administration in acute stadium only yield in increased compliance and willingness of the patients to accept such treatments</li> <li>Reduced side effects compared to standard therapies</li> <li>Use of the medicament only in acute need to acutely diminish a paraphilic sexual arousal state</li> <li>Ongoing clinical study</li> </ul> <strong>IP Rights</strong><br> An European Patent Application was filed in June 2009.<br> <br> <strong>Origin</strong><br> The novel therapeutic approach was developed by scientists from the Charité – Universitätsmedizin Berlin.</p> <p> </p>

Further Information: PDF

ipal GmbH
Phone: +49 (0)30/2125-4820

Contact
Dr. Dirk Dantz

info@technologieallianz.de | TechnologieAllianz e.V.
Further information:
http://www.technologieallianz.de/angebote.php?sort=sag&id=2739&lang=en
http://www.technologieallianz.de

More articles from Technology Offerings:

nachricht New Lithium Salts of Pentafluorophenylamide Anions as Electrolytes in Lithium Ionic Batteries
18.04.2017 | TechnologieAllianz e.V.

nachricht Gratings on glass surfaces
28.03.2017 | TechnologieAllianz e.V.

All articles from Technology Offerings >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: New megalibrary approach proves useful for the rapid discovery of new materials

Northwestern discovery tool is thousands of times faster than conventional screening methods

Different eras of civilization are defined by the discovery of new materials, as new materials drive new capabilities. And yet, identifying the best material...

Im Focus: Data storage using individual molecules

Researchers from the University of Basel have reported a new method that allows the physical state of just a few atoms or molecules within a network to be controlled. It is based on the spontaneous self-organization of molecules into extensive networks with pores about one nanometer in size. In the journal ‘small’, the physicists reported on their investigations, which could be of particular importance for the development of new storage devices.

Around the world, researchers are attempting to shrink data storage devices to achieve as large a storage capacity in as small a space as possible. In almost...

Im Focus: Data use draining your battery? Tiny device to speed up memory while also saving power

The more objects we make "smart," from watches to entire buildings, the greater the need for these devices to store and retrieve massive amounts of data quickly without consuming too much power.

Millions of new memory cells could be part of a computer chip and provide that speed and energy savings, thanks to the discovery of a previously unobserved...

Im Focus: An energy-efficient way to stay warm: Sew high-tech heating patches to your clothes

Personal patches could reduce energy waste in buildings, Rutgers-led study says

What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...

Im Focus: Lethal combination: Drug cocktail turns off the juice to cancer cells

A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.

The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

ICTM Conference 2019: Digitization emerges as an engineering trend for turbomachinery construction

12.12.2018 | Event News

New Plastics Economy Investor Forum - Meeting Point for Innovations

10.12.2018 | Event News

EGU 2019 meeting: Media registration now open

06.12.2018 | Event News

 
Latest News

New megalibrary approach proves useful for the rapid discovery of new materials

19.12.2018 | Materials Sciences

Artificial intelligence meets materials science

19.12.2018 | Materials Sciences

Gut microbiome regulates the intestinal immune system, researchers find

19.12.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>